Category: Digital Health

All Podcast Categories
S2-4 - What Can You Do Today to Prevent and Treat Fatty Liver Disease?

S2-4 – What Can You Do Today to Prevent and Treat Fatty Liver Disease?

Ken Cusi and Roger Green are joined by Diana Barb and Jay Shubrook in a discussion around effective therapies and strategies for fighting fatty liver disease that are available now. The group discusses frontline screening, medications, bariatric surgery, lifestyle management, practical insights and much more.

S4-8.6 - Previewing Innovations in NAFLD Care 2022: Day Two Sessions

S4-8.6 – Previewing Innovations in NAFLD Care 2022: Day Two Sessions

Learn about the amazingly diverse and exciting program for Day Two of the inaugural Innovations in NAFLD Care 2022 Workshop, with sessions on Comprehensive Care pathways, current and future pharmacotherapies, and what a future integrated treatment roadmap might look like.

S4-8.5 - The Future of Digital Therapeutics

S4-8.5 – The Future of Digital Therapeutics

The podcast ventures into the emergence of digital therapeutics with Joe Rubinsztain, CEO and Co-Founder of ChronWell, and Mark Berman, CMO of Better Therapeutics. In this final conversation, the panelists provide closing thoughts on the future of this space and how it may play out across different economic systems.

S4-8.4 - Digital Apps: Patient Participation and Regulatory Challenges

S4-8.4 – Digital Apps: Patient Participation and Regulatory Challenges

The podcast ventures into the emerging space of digital therapeutics with Joe Rubinsztain, CEO and Co-Founder of ChronWell, and Mark Berman, CMO of Better Therapeutics. The panelists consider regulatory challenges for prescribing digital therapeutics as an evidence-based treatment. Additionally, Louise Campbell introduces a free lifestyle app that she is working on that aims to improve liver health.

S4-8.3 - Joe Rubinsztain on ChronWell and Scalable Technology

S4-8.3 – Joe Rubinsztain on ChronWell and Scalable Technology

Joe Rubinsztain, CEO and Co-Founder of ChronWell, discusses scalable technology and the future of digital health. Within this context, the panelists consider the dynamics of insurers, providers and building an understanding around the full spectrum of disease treatment.

S4-8.1 - Utilizing Prescription Digital Therapeutics to Combat Fatty Liver

S4-8.1 – Utilizing Prescription Digital Therapeutics to Combat Fatty Liver

The podcast ventures into the emerging digital therapeutics space with Joe Rubinsztain, CEO and Co-Founder of ChronWell, and Mark Berman, CMO of Better Therapeutics. In this conversation, both guests share their unique backgrounds and paths to combating Fatty Liver through technological innovation.

Sponsoring Partnerships!

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.